A virtual format will enable innovative learning opportunities, increased schedule flexibility, and a new level of interaction between regulatory practitioners, industry experts, and government officials. Speakers will analyze the latest commercial issues related to advertising and promotion of human and animal drugs, medical devices, and biologics

Practical Takeaways: Sessions will explore updated government agency initiatives, goals, and priorities, product promotion in a remote environment, social media best practices, trends in pre- approval communications, effective patient engagement, and litigation risks.

Government Speakers: Representatives from various FDA Centers, the Federal Trade Commission, the Department of Health and Human Services Inspector General, and the Department of Justice will provide the latest information on policy, enforcement, and future initiatives.

Peer Interaction: The conference will prioritize virtual learning, engagement, and networking with fellow legal, regulatory, and marketing experts.

Planning Committee

Co-Chairs

Madhavi Bellamkonda, Intuitive Surgical Inc.
Bryant M. Godfrey, Foley Hoag LLP

Committee

Rebecca Burnett, Framework Solutions
Julie B. Chronis, Gilead Sciences, Inc.
Mary Ellen Dronitsky, Northeastern University
Virginia Foley, Opus Regulatory, Inc.
Mark Gaydos, Sanofi
Matthew Hegreness, Covington & Burling LLP
Mark Levy, Eckert Seamans Cherin & Mellott, LLC
Lauren A. Miller, AbbVie
Thomas Miller, Nixon GWILT Law
Gillian M. Russell, King & Spalding LLP
Victoria Tamarkin, Tamarkin Consulting LLC
Kyle Thomson, American Medical Association
Ashley Zborowsky, Medtronic